Role of Staphylococcus aureus catalase in niche competition against Streptococcus pneumoniae.

Division of Pediatric Infectious Diseases and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Journal of bacteriology (Impact Factor: 2.69). 05/2008; 190(7):2275-8. DOI: 10.1128/JB.00006-08
Source: PubMed

ABSTRACT Nasal colonization by Staphylococcus aureus is a major predisposing factor for subsequent infection. Recent reports of increased S. aureus colonization among children receiving pneumococcal vaccine implicate Streptococcus pneumoniae as an important competitor for the same niche. Since S. pneumoniae uses H2O2 to kill competing bacteria, we hypothesized that oxidant defense could play a significant role in promoting S. aureus colonization of the nasal mucosa. Using targeted mutagenesis, we showed that S. aureus expression of catalase contributes significantly to the survival of this pathogen in the presence of S. pneumoniae both in vitro and in a murine model of nasal cocolonization.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: One hundred and six S. aureus were isolated from 250 Nasal swabs of Healthcare workers and patients at Al- Kadhamia teaching Hospital and Al- Numan hospital, Baghdad, Iraq. The study was undertaken over a period of ten months between August 2011 and June 2012. S. aureus isolates were diagnosed based on phenotypic traits and biochemical tests. Antibiotics sensitivity to 11 antibiotics, revealed that S.aureus is totally resistant to Pencillin G (100%), highly resistant to Cefoxitin (alternative to Methicillin) (94.3%) While there are varied resistance percentage for the rest of antibiotics: Erythromycin (37.7%), Tetracycline (34.9%), Gentamicin (29.3%), Trimethoprim/sulfamethoxazole (50%), Ciprofloxacin (29.2%), and showed highly sensitive to Rifampin (96.2%), Clarithromycin (78.3%) and Clindamycin (73.6%),Whereas Vancomycin intermediate S. aureus (VISA) was 32.1% and 3.8% was Vancomycin resistant S. aureus (VRSA). The incidence of MRSA among S. aureus was 94.3%. It is concluded that S. aureus nasal carriage is a common health problem all over the world and Methicillin resistant S. aureus is an emerging subject even in our community, which requires further attention and support.
    Iraqi Journal of Science. 01/2013; 54(2):293-300.
  • [Show abstract] [Hide abstract]
    ABSTRACT: We describe a cutaneous abscess caused by catalase-negative methicillin-susceptible Staphylococcus aureus subsp. aureus in a patient who was concomitantly colonized with virulent USA300 methicillin-resistant S. aureus (MRSA). Sequencing of the katA gene demonstrated a thymine insertion leading to a frameshift mutation and premature truncation of catalase to 21 amino acids.
    Journal of clinical microbiology 10/2013; · 4.23 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Traumatology and orthopedic surgery can benefit from the use of efficient local antibiotic-eluting systems to avoid bacterial contamination of implanted materials. In this work a new percutaneous porous-wall hollow implant was successfully used as a local antibiotic-eluting device both in vitro and in vivo. The implant is a macroporous 316L stainless steel filter tube with a nominal filtration cut-off size of 200nm with one open end which was used to load the synthetic antibiotic linezolid and an opposite blind end. The antibiotic release kinetics from the device on a simulated biological fluid under in vitro conditions demonstrated an increased concentration during the first five days that subsequently was sustained for at least seven days, showing a kinetic close to a zero order release. Antibiotic-loaded implants were placed in the tibia of four sheep which were trans-surgically experimentally infected with a biofilm forming strain of Staphylococcus aureus. After 7 and 9 days post infection, sheep did not show any evidence of infection as demonstrated by clinical, pathological and microbiological findings. These results demonstrate the capability of such an antibiotic-loaded implant to prevent infection in orthopedic devices in vivo. Further research is needed to assess its possible use in traumatology and orthopedic surgery.
    International Journal of Pharmaceutics 05/2013; · 3.99 Impact Factor


Available from